Concepedia

Miyuki Mabuchi

MM

Statistics

Publications

10

Citations

705

H-Index

10

Active since

2000

Affiliations

Hyogo University of Health Sciences(Current)

Mochida Pharmaceutical (Japan)

The University of Osaka

Fujisawa City Hospital

Miyuki Mabuchi is an author at Hyogo University of Health Sciences specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryPharmacotherapyMedicinal ChemistryTumor BiologyCancer TherapyNatural SciencesMolecular Pharmacology

Publications per year

2000–2018

10

Publications

10

Selective degradation of splicing factor CAPERα by anticancer sulfonamides

Taisuke Uehara, Yukinori Minoshima, Koji Sagane et al. · Nature Chemical Biology · 2017 · 366 citations

Medicinal Chemistry, Medicine, Natural Sciences +6

Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs

Syuhei Nakao, Miyuki Mabuchi, Tadashi Shimizu et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 83 citations · Full text

Medicinal Chemistry, Medicine, Anti-prostate Cancer Drugs +8

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614

Hideaki Minoura, Shigeru Takeshita, Makoto Ita et al. · European Journal of Pharmacology · 2004 · 79 citations

Molecular Pharmacology, Pharmacological Characteristics, Biochemistry +7

LESSER REDUCTION IN BONE MINERAL DENSITY BY THE IMMUNOSUPPRESSANT, FK506, COMPARED WITH CYCLOSPORINE IN RATS

Takeshi Inoue, Ikuo Kawamura, Masahiko Matsuo et al. · Transplantation · 2000 · 60 citations

Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor γ agonist, on insulin resistance in Zucker fatty rat

Hideaki Minoura, Shigeru Takeshita, Tadashi Yamamoto et al. · European Journal of Pharmacology · 2005 · 34 citations

Insulin Resistance, Metabolic Syndrome, Health Sciences +10

1–5 of 10